Alzheimer Disease & Associated Disorders

Papers
(The TQCC of Alzheimer Disease & Associated Disorders is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Rescreening on RBANS Delayed Memory Index? Forget About It!17
Meta-Analysis of Animal Fluency Performance in Amnestic Mild Cognitive Impairment and Cognitively Unimpaired Older Adults17
Psychometric Evaluation of the Perceived Research Burden Assessment (PeRBA) in Longitudinal Studies of Alzheimer Disease Using Rasch Analysis17
Alzheimer’s Disease Neuropathologic Change and Vitamin Supplement Use Decades Earlier13
A Randomized Double-blind Study to Assess the Skin Irritation and Sensitization Potential of a Once-weekly Donepezil Transdermal Delivery System in Healthy Volunteers12
Caring for the Caregivers11
Utility of the Repeat and Point Test for Subtyping Patients With Primary Progressive Aphasia10
Anticipated Psychological or Behavioral Reactions to Learning Alzheimer Biomarker Results9
Focusing on Earlier Management of Alzheimer Disease9
Frequent Occurrence of Alzheimer Disease in Patients With IgE-mediated Allergies9
Pure Prosodic Type of Primary Progressive Apraxia of Speech Mimicking Nonfluent Aphasia and Later Progressing to Corticobasal Syndrome8
Asian Cohort for Alzheimer Disease (ACAD) Pilot Study8
Thank You to Our Reviewers in 2021!7
The Technology in Caring Questionnaire7
Alzheimer Disease: A New Beginning in Therapeutics7
Mild Cognitive Impairment Subtype Performance in Comparison to Healthy Older Controls on the NIH Toolbox and Cogstate7
Effects of Depression on Changes in Cognitive Function in Older Adults7
Characterization of Balance Control and Postural Stability in Patients With Alzheimer Disease6
Recruitment of a Diverse Community-based Older Adult Cohort for a Longitudinal Aging Study6
Interaction of Alzheimer Disease and Traumatic Brain Injury on Cortical Thickness6
The Impact of Episodes of Lucidity on People Living With Dementia and Their Caregivers6
Clinical Characterization of Veterans With Alzheimer Disease by Disease Severity in the United States6
Triadic Communication in Medical Encounters Including Individuals With Dementia6
Familiarity in Mild Cognitive Impairment as a Function of Patients’ Clinical Outcome 4 Years Later6
Risk of Neuropsychiatric Symptoms Among People Who Develop Cognitive Impairment With and Without a History of Post-traumatic Stress Disorder6
The Influence of Traffic Lights Presentation of Dementia Risk Screening Information on Older Adults’ Motivations for Risk Reduction in Primary Care Settings5
Decreased Expression of Cerebral Dopamine Neurotrophic Factor in Platelets of Probable Alzheimer Patients5
DXA-Measured Abdominal Adipose Depots and Structural Brain Integrity in Postmenopausal Women5
GAD65 Autoimmune Encephalitis5
Exploring Social Cognition Tests to Differentiate Frontotemporal Dementia from Depression5
Hypothesis5
MoCA Intraindividual Cognitive Variability in Older Adults With Type 1 Diabetes5
Carotid Intima-Media Thickness (cIMT) and Cognitive Performance: A Population-Based Cross-Sectional Study from North India: Erratum5
Perspectives From Black and White Participants and Care Partners on Return of Amyloid and Tau PET Imaging and Other Research Results5
Compassion Versus Accuracy5
Healthy Lifestyle Behaviors and Viewpoints Among Members of an Alzheimer Prevention Registry4
A New Presenilin-1 Missense Variant Associated With a Progressive Supranuclear Palsy-like Phenotype4
A Pilot Randomized Trial of a Purposeful and Stimulating Volunteer Opportunity4
Reply to: Brain Volumes, Cognitive Decline, and Physical Activity in Older Inhabitants4
Measurement of Allostatic Load in Caregivers of Older Hispanic People With Alzheimer Disease and Related Disorders4
Phase 1 Single Ascending and Multiple Ascending Dose Studies of Phosphodiesterase-9 Inhibitor E20274
“I′m not a risk taker”4
Genetic Variants and Haplotypes of TOMM40, APOE, and APOC1 are Related to the Age of Onset of Late-onset Alzheimer Disease in a Colombian Population4
CSF α-Synuclein and Tau as Biomarkers for Dementia With Lewy Bodies4
Bone Mineral Density Measurements and Association With Brain Structure and Cognitive Function4
Regional White Matter Hyperintensities Relate to Specific Cognitive Abilities in Older Adults Without Dementia4
Application of Suggestive Biomarkers in Dementia With Lewy Bodies With Masking of Typical Clinical Symptoms by Alzheimer Disease-type Pathology4
Intravesical BCG and Incidence of Alzheimer Disease in Patients With Bladder Cancer4
A Delphi Approach to Define Lucid Episodes in People Living With Dementia4
Evidence of Pericyte Damage in a Cognitively Normal Cohort4
Meta-Analysis of White Matter Hyperintensity Volume Differences Between APOE ε4 Carriers and Noncarriers4
Mapping the Landscape of Those Left Behind When a Person With Dementia Dies4
Relapse in Dementia-related Psychosis and Clinical Decisions4
0.098510026931763